TNF-α Induction by nickel compounds is specific through ERKs/AP-1-dependent pathway in human bronchial epithelial cells

Current Cancer Drug Targets

Volumn 9, Issue 1, 2009, Pages 81-90

  Ding, Jin ^a,c   Huang, Yi ^b   Ning, Beifang ^c   Gong, Wenfeng ^c   Li, Jingxia ^a   Wang, Hongyang ^c   Chen, Chang Yan ^b   Huang, Chuanshu ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Kinase; Lung; Nickel; TNF ; Transcriptional factor

Indexed keywords

I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICKEL; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; EXPOSURE; HUMAN; HUMAN CELL; INHIBITION KINETICS; MUTANT; PROTEIN EXPRESSION; PROTEIN INDUCTION;

BRONCHI; CELL LINE; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; NICKEL; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 62549132082     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800909787313995     Document Type: Article

References (54)

1. IARC monographs on the evaluation of the carcinogenic risk of chemicals to man: cadmium, nickel, some epoxides, miscellaneous industrial chemicals and general consideration on volatile anaesthetics. IARC Monogr. Eval. Carcinog. Risk Chem. Man 1976, 11, 1-293.
2. Sivulka, D. J. Assessment of respiratory carcinogenicity associated with exposure to metallic nickel: a review. Regul. Toxicol. Pharmacol. 2005, 43, 117-133.
3. Bennett, B. G. Environmental nickel pathways to man. IARC Sci. Pub. 1984, 53, 487-495.
4. Doll, R.; Morgan, L. G.; Speizer, F. E. Cancers of the lung and nasal sinuses in nickel workers. Br. J. Cancer 1970, 24, 623-632.
5. Shen, H. M.; Zhang, Q. F. Risk assessment of nickel carcinogenicity and occupational lung cancer. Environ. Health Perspect. 1994, 102(Suppl. 1), 275-282.
6. Langard, S. Nickel-related cancer in welders. Sci. Total Environ. 1994, 148, 303-309.
7. Salnikow, K.; Costa, M. Epigenetic mechanisms of nickel carcino-genesis. J. Environ. Pathol. Toxicol. Oncol. 2000, 19, 307-318.
8. Trubnikov, G. Level of microelements in the sputum of patients with inflammatory and tumorous processes of the lungs. Ter. Arkh. 1975, 47, 132-137.
9. Trubnikov, G. Nickel, aluminum and chromium levels in the blood plasms of patients with chronic pneumonia. Ter. Arkh. 1969, 41, 69-72.
10. Trubnikov, G.; Fomin, A. Blood plasma iron, copper, manganese, aluminum, nickel and chromium content in inflammatory diseases of the lungs and bronchial asthma. Sov. Med. 1968, 31, 137-138.
11. Kasprzak, K.; Marchow, L.; Breborowicz, J. Pathological reactions in rat lungs following intratracheal injection of nickel subsulfide and 3,4-benzpyrene. Res. Commun. Chem. Pathol. Pharmacol. 1973, 1, 237-245.
12. Borg, L.; Christensen, J. M.; Kristiansen, J. Nielsen, N. H.; Menne, T.; Poulsen, L. K. Nickel-induced cytokine production from mono- nuclear cells in nickel-sensitive individuals and controls. Cytokine profiles in nickel-sensitive individuals with nickel allergy-related hand eczema before and after nickel challenge. Arch. Dermatol. Res. 2000, 292, 285-291.
13. Lisby, S.; Muller, K. M.; Jongeneel, C. V.; Saurat, J. H.; Hauser, C. Nickel and skin irritants up-regulate tumor necrosis factor-alpha mRNA in keratinocytes by different but potentially synergistic mechanisms. Int. Immunol. 1995, 7, 343-352.
14. Morimoto, Y.; Nambu, Z.; Tanaka, I.; Higashi, T.; Yamato, H.; Hori, H.; Cho, S.; Kido, M. Effects of nickel oxide on the production of tumor necrosis factor by alveolar macrophages of rats. Biol. Trace Elem. Res. 1995, 48, 287-296.
15. Chen, C. Y.; Huang, Y. L.; Lin, T. H. Association between oxidative stress and cytokine production in nickel-treated rats. Arch. Biochem. Biophys. 1998, 356, 127-132.
16. Zhang, Q.; Kusaka, Y.; Zhu, X.; Sato, K.; Mo, Y.; Kluz, T.; Donaldson, K. Comparative toxicity of standard nickel and ultrafine nickel in lung after intratracheal instillation. J. Occup. Health 2003, 45, 23-30.
17. Zhang, X.; Ye, J.; Wang, L.; Manosroi, J.; Shi, X.; Rojanasakul, Y. Rapid and sensitive assay of tumor necrosis factor-alpha gene transcription. Pharm. Res. 2001, 78, 408-411.
18. Cooper, S. J.; MacGowan, J.; Ranger-Moore, J.; Young, M. R; Colburn, N. H.; Bowden, G. T. Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model. Mol. Cancer Res. 2003, 1, 848-854.
19. Ding, J.; Li, J.; Chen, J.; Chen, H.; Ouyang, W.; Zhang, R. Xue, C.; Zhang, D.; Amin, S.; Desai, D.; Huang, C. Effects of polycyclic aromatic hydrocarbons (PAHs) on vascular endothelial growth factor induction through phosphatidylinositol 3-kinase/AP-1- dependent, HIF-1alpha-independent pathway. J. Biol. Chem. 2006, 287, 9093-9100.
20. Li, J.; Chen, H.; Ke, Q.; Feng, Z.; Tang, M. S.; Liu, B. Amin, S.; Costa, M.; Huang, C. Differential effects of polycyclic aromatic hydrocarbons on transactivation of AP-1 and NF-kappaB in mouse epidermal cl41 cells. Mol. Carcinog. 2004, 40, 104-115.
21. Rincon, M.; Flavell, R. A. Transcription mediated by NFAT is highly inducible in effector CD4+ T helper 2 (Th2) cells but not in Th1 cells. Mol. Cell Biol. 1997, 17, 1522-1534.
22. Chow, C. W.; Rincon, M.; Davis, R. J. Requirement for transcription factor NFAT in interleukin-2 expression. Mol. Cell Biol. 1999, 19, 2300-2307.
23. Li, J.; Davidson, G.; Huang, Y.; Jiang, B. H.; Shi, X.; Costa, M.; Huang, C. Nickel compounds act through phosphatidylinositol-3- kinase/Akt-dependent, p70(S6k)-independent pathway to induce hypoxia inducible factor transactivation and Cap43 expression in mouse epidermal Cl41 cells. Cancer Res. 2004, 64, 94-101.
24. Huang, C.; Ma, W.; Ding, M.; Bowden, G. T.; Dong, Z. Direct evidence for an important role of sphingomyelinase in ultraviolet- induced activation of c-Jun N-terminal kinase. J. Biol. Chem. 1997, 272, 27753-27757.
25. Joyce, D.; Bouzahzah, B.; Fu, M.; Albanese, C.; D'Amico, M.; Steer, J.; Klein, J. U.; Lee, R. J.; Segall, J. E.; Westwick, J. K.; Der, C. J.; Pestell, R. G. Integration of Rac-dependent regulation of cy-clin D1 transcription through a nuclear factor-kappaB-dependent pathway. J. Biol. Chem. 1999, 274, 25245-25249.
26. Ding, J.; Zhang, X.; Li, J.; Song, L.; Ouyang, W.; Zhang, D.; Xue, C.; Costa, M.; Meléndez, J. A.; Huang, C. Nickel compounds render anti-apoptotic effect to human bronchial epithelial Beas-2B cells by induction of cyclooxygenase-2 through an IKKbeta/p65- dependent and IKKalpha- and p50-independent pathway. J. Biol. Chem. 2006,281, 39022-39032.
27. Szlosarek, P.; Charles, K. A.; Balkwill, F. R. Tumour necrosis factor-alpha as a tumour promoter. Eur. J. Cancer 2006, 42, 745-750.
28. Goutet, M.; Ban, M.; Binet, S. Effects of nickel sulfate on pulmonary natural immunity in Wistar rats. Toxicology 2000, 145, 15-26.
29. Harkin, A.; Hynes, M. J.; Masterson, E.; Kelly, J. P.; O'Donnell, J. M.; Connor, T. J. A toxicokinetic study of nickel-induced immunosuppression in rats. Immunopharmacol. Immunotoxicol. 2003, 25, 655-670.
30. Boisleve, F.; Kerdine-Romer, S.; Rougier-Larzat, N.; Pallardy, M. Nickel and DNCB induce CCR7 expression on human dendritic cells through different signalling pathways: role of TNF-alpha and MAPK. J. Invest. Dermatol. 2004, 123, 494-502.
31. Oum, J. H; Han, J.; Myung, H.; Hleb, M.; Sharma, S.; Park, J. Molecular mechanism of NFAT family proteins for differential regulation of the IL-2 and TNF-alpha promoters. Mol. Cells 2002, 13, 77-84.
32. Becker, C.; Barbulescu, K.; Wirtz, S.; Meyer zum Buschenfelde, K. H.; Pettersson, S.; Neurath, M. F. Constitutive and inducible in vivo protein-DNA interactions at the tumor necrosis factor-alpha promoter in primary human T lymphocytes. Gene Expr. 1999, 8, 115-127.
33. Ke, Q.; Li, J.; Ding, J.; Ding, M.; Wang, L.; Liu, B.; Coata, M.; Huang, C. Essential role of ROS-mediated NFAT activation in TNF-alpha induction by crystalline silica exposure. Am. J. Physiol. Lung Cell Mol. Physiol. 2006, 29, L257-L264.
34. Novotny, V.; Prieschl, E. E.; Csonga, R.; Fabjani, G.; Baumruker, T. Nrf1 in a complex with fosB, c-jun, junD and ATF2 forms the AP1 component at the TNF alpha promoter in stimulated mast cells. Nucleic Acids Res. 1998, 26, 5480-5485.
35. Prieschl, E. E.; Novotny, V.; Csonga, R.; Jaksche, D.; Elbe-Burger, A.; Thumb, W.; Auer, M.; Stingl, G.; Baumruker, T. A novel splice variant of the transcription factor Nrf1 interacts with the TNFalpha promoter and stimulates transcription. Nucleic Acids Res. 1998, 26, 2291-2297.
36. Csonga, R.; Prieschl, E. E.; Jaksche, D.; Novotny, V.; Baumruker, T. Common and distinct signaling pathways mediate the induction of TNF-alpha and IL-5 in IgE plus antigen-stimulated mast cells. J. Immunol. 1998, 160, 273-283.
37. Park, P. H.; McMullen, M. R.; Huang, H.; Thakur, V.; Nagy, L. E. Short-term treatment of RAW264.7 macrophages with adiponectin increases tumor necrosis factor-alpha (TNF-alpha) expression via ERK1/2 activation and Egr-1 expression: role of TNF-alpha in adi-ponectin-stimulated interleukin-10 production. J. Biol. Chem. 2007, 282, 21695-21703.
38. Hayden, M. S.; Ghosh, S. Signaling to NF-kappaB. Genes Dev. 2004, 18, 2195-2224.
39. Karin, M.; Greten, F. R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 2005, 5, 749-759.
40. Ding, J.; Li, J.; Xue, C.; Wu, K.; Ouyang, W.; Zhang, D.; Yan, Y.; Huang, C. Cyclooxygenase-2 induction by arsenite is through a nuclear factor of activated T-cell-dependent pathway and plays an an-tiapoptotic role in Beas-2B cells. J. Biol. Chem. 2006, 281, 24405-24413.
41. Hess, J.; Angel, P.; Schorpp-Kistner, M. AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 2004, 117(Pt. 25), 5965-5973.
42. Karin, M. The regulation of AP-1 activity by mitogen-activated protein kinases. Philos. Trans. R Soc. Lond. B Biol. Sci. 1996, 351, 127-134.
43. Ouyang, W.; Ma, Q.; Li, J.; Zhang, D.; Ding, J.; Huang, Y.; Xing, M. M.; Huang, C. Benzo[a]pyrene diol-epoxide (B[a]PDE) upregu-lates COX-2 expression through MAPKs/AP-1 and IKKbeta/NF-kappaB in mouse epidermal Cl41 cells. Mol. Carcinog. 2007, 46, 32-41.
44. Bancroft, C. C.; Chen, Z.; Yeh, J.; Sunwoo, J. B.; Yeh, N. T.; Jackson, S. Jackson, C.; Van, W. C. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int. J. Cancer 2002, 99, 538-548.
45. Hilberg, F.; Aguzzi, A.; Howells, N.; Wagner, E. F. c-jun is essential for normal mouse development and hepatogenesis. Nature 1993, 365, 179-181.
46. Grigoriadis, A. E.; Schellander, K.; Wang, Z. Q.; Wagner, E. F. Osteoblasts are target cells for transformation in c-fos transgenic mice. J. Cell Biol. 1993, 122, 685-701.
47. Lamb, R. F.; Hennigan, R. F.; Turnbull, K.; Katsanakis, K. D.; MacKenzie, E. D.; Birnie, G. D.; Ozanne, B. W. AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44. Mol. Cell Biol. 1997, 17, 963-976.
48. Jochum, W.; Passegue, E.; Wagner, E. F. AP-1 in mouse development and tumorigenesis. Oncogene 2001, 20, 2401-2412.
49. Balkwill, F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev. 2006, 25, 409-416.
50. Lejeune, F. J. Clinical use of TNF revisited: improving penetration of anti-cancer agents by increasing vascular permeability. J. Clin. Invest. 2002, 110, 433-435.
51. Moore, R. J.; Owens, D. M.; Stamp, G.; Arnott, C.; Burke, F.; East, N.; Holdsworth, H.; Turner, L.; Rollins, B.; Pasparakis, M.; Kol-lias, G.; Balkwill, F. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat. Med. 1999, 5, 828-831.
52. Scott, K. A.; Arnott, C. H.; Robinson, S. C.; Moore, R. J.; Thompson, R. G.; Marshall, J. F.; Balkwill, F. R. TNF-alpha regulates epithelial expression of MMP-9 and integrin alphavbeta6 during tumour promotion. A role for TNF-alpha in keratinocyte migration? Oncogene 2004, 23, 6954-6966.
53. Orosz, P.; Echtenacher, B.; Falk, W.; Ruschoff, J.; Weber, D.; Mannel, D. N. Enhancement of experimental metastasis by tumor necrosis factor. J. Exp. Med. 1993, 177, 1391-1398.
54. Yan, Y.; Li, J.; Ouyang, W.; Ma, Q.; Hu, Y.; Zhang, D. Ding, J.; Qu, Q.; Subbaraminaha, K.; Huang, C. NFAT3 is specifically required for TNF-{alpha}-induced cyclooxygenase-2 (COX-2) expression and transformation of Cl41 cells. J. Cell Sci. 2006, 119, 2985-2994.